NO179206C - Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-amino-4-morfolino-6-propyl-1,3,5-triaziner - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-amino-4-morfolino-6-propyl-1,3,5-triaziner

Info

Publication number
NO179206C
NO179206C NO893279A NO893279A NO179206C NO 179206 C NO179206 C NO 179206C NO 893279 A NO893279 A NO 893279A NO 893279 A NO893279 A NO 893279A NO 179206 C NO179206 C NO 179206C
Authority
NO
Norway
Prior art keywords
alkyl
triazines
morpholino
propyl
amino
Prior art date
Application number
NO893279A
Other languages
English (en)
Norwegian (no)
Other versions
NO893279L (no
NO179206B (no
NO893279D0 (no
Inventor
Eric Cossement
Jean Gobert
Roland Boydens
Jacques Mathieu
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of NO893279D0 publication Critical patent/NO893279D0/no
Publication of NO893279L publication Critical patent/NO893279L/no
Publication of NO179206B publication Critical patent/NO179206B/no
Publication of NO179206C publication Critical patent/NO179206C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/08—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Cosmetics (AREA)
NO893279A 1988-08-16 1989-08-15 Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-amino-4-morfolino-6-propyl-1,3,5-triaziner NO179206C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888819493A GB8819493D0 (en) 1988-08-16 1988-08-16 2-amino-4-morpholino-6-propyl-1 3 5-triazines

Publications (4)

Publication Number Publication Date
NO893279D0 NO893279D0 (no) 1989-08-15
NO893279L NO893279L (no) 1990-02-19
NO179206B NO179206B (no) 1996-05-20
NO179206C true NO179206C (no) 1996-08-28

Family

ID=10642235

Family Applications (1)

Application Number Title Priority Date Filing Date
NO893279A NO179206C (no) 1988-08-16 1989-08-15 Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-amino-4-morfolino-6-propyl-1,3,5-triaziner

Country Status (28)

Country Link
US (1) US4956367A (lt)
EP (1) EP0356413B1 (lt)
JP (1) JPH02108675A (lt)
KR (1) KR0136108B1 (lt)
AT (1) ATE72241T1 (lt)
AU (1) AU614247B2 (lt)
CA (1) CA1317944C (lt)
CY (1) CY1709A (lt)
DE (1) DE68900794D1 (lt)
DK (1) DK171698B1 (lt)
ES (1) ES2038849T3 (lt)
FI (1) FI102065B (lt)
GB (1) GB8819493D0 (lt)
GR (1) GR3004267T3 (lt)
HK (1) HK95693A (lt)
HU (1) HUT58087A (lt)
IE (1) IE61205B1 (lt)
IL (1) IL91243A (lt)
LT (1) LT3601B (lt)
MY (1) MY105008A (lt)
NO (1) NO179206C (lt)
NZ (1) NZ230290A (lt)
PL (2) PL161591B1 (lt)
PT (1) PT91438B (lt)
RU (3) RU1806142C (lt)
SG (1) SG27893G (lt)
UA (1) UA11064A (lt)
ZA (1) ZA896222B (lt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9024617D0 (en) * 1989-12-05 1991-01-02 Ici Plc Heterocyclic compounds
GB9008818D0 (en) * 1990-04-19 1990-06-13 Ici Plc Amine derivatives
IT1240690B (it) * 1990-04-30 1993-12-17 Ciba Geigy Ag Composti piperdin-triazinici atti all'impiego come stabilizzanti per materiali organici
GB9116039D0 (en) * 1991-07-25 1991-09-11 Ucb Sa Substituted cyclopropylamino-1,3,5-triazines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549757A (en) * 1968-03-27 1970-12-22 Shell Oil Co Use of 2-morpholino - 4 - amino-6-substituted-s-triazines for inducing depressant effects in animals
JPS4969688A (lt) * 1972-11-02 1974-07-05
FR2262512A1 (en) * 1974-03-01 1975-09-26 Synthelabo 2,4,6-Tri-substd. -1,3,5-triazines - with analgesic and psychotropic activity

Also Published As

Publication number Publication date
MY105008A (en) 1994-07-30
LTIP829A (en) 1995-02-27
ATE72241T1 (de) 1992-02-15
GB8819493D0 (en) 1988-09-21
FI102065B1 (fi) 1998-10-15
NZ230290A (en) 1991-10-25
IL91243A (en) 1995-05-26
GR3004267T3 (lt) 1993-03-31
PL161161B1 (pl) 1993-05-31
FI102065B (fi) 1998-10-15
RU1822403C (ru) 1993-06-15
JPH02108675A (ja) 1990-04-20
RU1806142C (ru) 1993-03-30
DE68900794D1 (en) 1992-03-12
EP0356413B1 (fr) 1992-01-29
IL91243A0 (en) 1990-03-19
US4956367A (en) 1990-09-11
ES2038849T3 (es) 1993-08-01
CA1317944C (en) 1993-05-18
DK171698B1 (da) 1997-03-24
EP0356413A1 (fr) 1990-02-28
ZA896222B (en) 1990-05-30
LT3601B (en) 1995-12-27
DK398189A (da) 1990-02-17
IE892619L (en) 1990-02-16
NO893279L (no) 1990-02-19
AU614247B2 (en) 1991-08-22
RU1838312C (ru) 1993-08-30
FI893714A0 (fi) 1989-08-07
UA11064A (uk) 1996-12-25
KR900003165A (ko) 1990-03-23
FI893714A (fi) 1990-02-17
NO179206B (no) 1996-05-20
HUT58087A (en) 1992-01-28
KR0136108B1 (ko) 1998-04-25
PT91438A (pt) 1990-03-08
CY1709A (en) 1994-01-14
IE61205B1 (en) 1994-10-19
AU3991789A (en) 1990-04-05
HK95693A (en) 1993-09-24
PL161591B1 (pl) 1993-07-30
DK398189D0 (da) 1989-08-14
PT91438B (pt) 1995-05-04
SG27893G (en) 1993-06-25
NO893279D0 (no) 1989-08-15

Similar Documents

Publication Publication Date Title
DE59003587D1 (de) Diarylacetylene, ihre Herstellung und Verwendung.
NO912429L (no) Fremgangsmaate for fremstilling av aralifatiske n-substituerte aminoalkanfosfinsyrer.
ATE188965T1 (de) Neue pyrazincarboxamidderivate, ihre herstellung und ihre verwendung in arzneimitteln
NO902800D0 (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
FR2689127B1 (fr) Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.
NO302523B1 (no) Heterosykliske forbindelser, farmasöytiske preparater som omfatter dem, og anvendelse av forbindelsene for fremstilling av medikamenter
ATE75942T1 (de) Verwendung von 2-amino-4-morpholino-6-propyl1,3,5-triazin zur herstellung eines medikaments zur behandlung kognitiver und mentaler erkrankungen.
IL83141A0 (en) Solutions of oxazophorins having improved stability and their preparation
NO179206C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-amino-4-morfolino-6-propyl-1,3,5-triaziner
ES2032501T3 (es) Un procedimiento de preparacion de derivados de urileno-2,4,6-triamino-3-oxido.
GR3017916T3 (en) 3,4-Disubstituted phenyl-heterocycles and their use.
HU896775D0 (en) Fungicid compositions comprising sulfurous oximethers as active ingredient and process for preparation thereof
IL90043A0 (en) Sulfonanilides,their preparation and pharmaceutical compositions containing them
DE68922596D1 (de) 3-(3-Ethyl-1,2,4-oxadiazol-5-yl)-1-azabicycloheptan, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zubereitungen.
HU905030D0 (en) Process for producing new 1,3-oxazines and pharmaceutical preparatives containing these compounds
ATE134135T1 (de) Ein imidazobenzodiazepin zur behandlung von schlafstörungen